Disc Medicine Inc (IRON)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Georges Gemayel
Employees:
30
300 ONE KENDALL SQUARE, 3RD FLOOR, CAMBRIDGE, MA, 02139
(617) 401-4400

Gemini Therapeutics, Inc. engages in developing therapeutic compounds for treating genetically defined age-related macular degeneration (AMD) Its lead candidate is GEM103, a recombinant form of the human complement factor H protein. The company also develops GEM307 for treatment of systemic diseases.

Data derived from most recent annual or quarterly report
Market Cap 987.019 Million Shares Outstanding43.328 Million Avg 30-day Volume 105.644 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.08
Price to Revenue0.0 Debt to Equity0.0 EBITDA-43.796 Million
Price to Book Value0.6786 Operating Margin0.0 Enterprise Value-30.783 Million
Current Ratio71.492 EPS Growth0.585 Quick Ratio69.493
1 Yr BETA -0.3507 52-week High/Low 26.43 / 1.18 Profit Margin0.0
Operating Cash Flow Growth23.9241 Altman Z-Score26.1064 Free Cash Flow to Firm -36.114 Million

Are you looking for this stock instead?

View SEC Filings from IRON instead.

View recent insider trading info

Funds Holding IRON (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding IRON

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Events (8k)

  • 8-K: filed on 2023-02-14:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-01-25:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-01-23:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-12-29:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.01: Completion of Acquisition or Disposition of Assets
    Item 3.02: Unregistered Sales of Equity Securities
    Item 3.03: Material Modifications to Rights of Security Holders
    Item 5.01: Changes in Control of Registrant
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 5.05: Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
    Item 7.01: Regulation FD Disclosure
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-12-28:
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 8.01: Other Events
  • 8-K: filed on 2022-12-27:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-12-13:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-12-08:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2022-10-31:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-08-10:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • Proposed Sales (Form 144)

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    652.2 Thousand total shares from 7 transactions

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    ORBIMED ADVISORS LLC

    ORBIMED CAPITAL GP VI LLC

    ORBIMED CAPITAL GP VIII LLC

    ORBIMED GENESIS GP LLC

    • Director
    • 10% Owner
    2,269,637 2023-02-15 3

    AI DMI LLC

    ACCESS INDUSTRIES HOLDINGS LLC

    ACCESS INDUSTRIES MANAGEMENT, LLC

    BLAVATNIK LEN

    • 10% Owner
    3,141,759 2023-02-15 2

    ASHIYA MONA

    • Director
    • 10% Owner
    2,269,637 2023-02-15 3

    GEMAYEL GEORGES

    • Director
    7,000 2022-12-29 1

    NOVO HOLDINGS A/S

    • 10% Owner
    2,340,772 2022-12-29 1

    RATCLIFFE LIAM

    • Director
    0 2022-12-29 2

    QUISEL JOHN D CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    0 2022-12-29 2

    BITTERMAN KEVIN

    • Director
    1,173,482 2022-12-29 2

    ATLAS VENTURE FUND X, L.P.

    ATLAS VENTURE ASSOCIATES X, L.P.

    ATLAS VENTURE ASSOCIATES X, LLC

    ATLAS VENTURE OPPORTUNITY FUND I, L.P.

    ATLAS VENTURE ASSOCIATES OPPORTUNITY I, L.P.

    ATLAS VENTURE ASSOCIATES OPPORTUNITY I, LLC

    • 10% Owner
    3,192,459 2022-12-29 1

    CHIN MARK

    • Director
    0 2022-12-29 2

    WHITE WILLIAM RICHARD

    • Director
    7,000 2022-12-29 2

    BACKSTROM JAY T.

    • Director
    7,000 2022-12-29 2

    NICHOLSON DONALD WILLIAM

    • Director
    7,000 2022-12-29 2

    ATLAS VENTURE OPPORTUNITY FUND II, L.P.

    ATLAS VENTURE ASSOCIATES OPPORTUNITY II, LP

    ATLAS VENTURE ASSOCIATES OPPORTUNITY II, LLC

    • 10% Owner
    218,326 2022-12-29 1

    BRYCE JOANNE CHIEF FINANCIAL OFFICER

    • Officer
    3,452 2022-12-29 2

    YU JONATHAN YEN-WEN CHIEF BUSINESS OFFICER

    • Officer
    0 2022-12-29 2

    KHARA RAHUL GENERAL COUNSEL

    • Officer
    0 2022-12-29 2

    SAVAGE WILLIAM JACOB CHIEF MEDICAL OFFICER

    • Officer
    20,325 2022-12-29 2

    MACDONALD BRIAN RICHARD CHIEF INNOVATION OFFICER

    • Officer
    28,496 2022-12-29 2

    LEONARD BRADEN MICHAEL

    • 10% Owner
    5,247,500 2022-10-26 3

    PIEKOS BRIAN CFO

    • Officer
    17,615 2022-05-31 1

    MEYENBURG JASON PATRICK CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    123,600 2022-01-03 0

    GORDON CARL L

    • Director
    • 10% Owner
    17,245 2021-10-04 0

    LUBNER DAVID CHARLES

    • Director
    17,245 2021-10-04 0

    RHODES JASON P

    • Director
    • 10% Owner
    17,245 2021-10-04 0

    TANANBAUM JAMES B.

    • Director
    • 10% Owner
    428,745 2021-10-04 0

    ONG TUYEN

    • Director
    17,245 2021-10-04 0

    STRAPPS WALTER CHIEF SCIENTIFIC OFFICER

    • Officer
    9,000 2021-04-28 0

    BARONE SAMUEL B. CHIEF MEDICAL OFFICER

    • Officer
    255,212 2021-04-12 0

    LAUDER SCOTT CHIEF TECHNOLOGY OFFICER

    • Officer
    272,615 2021-02-23 0

    REDMOND PRECILLIA CHIEF PEOPLE OFFICER

    • Officer
    25,489 2021-02-23 0

    ORBIMED ADVISORS LLC

    ORBIMED CAPITAL GP VI LLC

    • Director
    • 10% Owner
    5,826,224 2021-02-05 3

    BELOFF GREGG CHIEF FINANCIAL OFFICER

    • Officer
    0 2021-02-05 0

    GEORGE JEAN

    • Director
    • 10% Owner
    4,836,106 2021-02-05 0

    LSV ASSOCIATES, LLC

    LIGHTSTONE VENTURES, L.P.

    LIGHTSTONE VENTURES (A), L.P.

    LIGHTSTONE SINGAPORE, L.P.

    LIGHTSTONE SINGAPORE ASSOCIATES, LLC

    CARUSI MICHAEL A

    PLAIN HENRY A JR

    • 10% Owner
    4,836,106 2021-02-05 0

    ATLAS VENTURE FUND X, L.P.

    ATLAS VENTURE ASSOCIATES X, L.P.

    ATLAS VENTURE ASSOCIATES X, LLC

    ATLAS VENTURE OPPORTUNITY FUND I, L.P.

    ATLAS VENTURE ASSOCIATES OPPORTUNITY I, L.P.

    ATLAS VENTURE ASSOCIATES OPPORTUNITY I, LLC

    ATLAS VENTURE FUND XII, L.P.

    ATLAS VENTURE ASSOCIATES XII, L.P.

    ATLAS VENTURE ASSOCIATES XII, LLC

    • 10% Owner
    5,254,365 2021-02-05 1

    FS DEVELOPMENT HOLDINGS, LLC

    FORESITE CAPITAL FUND V, L.P.

    FORESITE CAPITAL MANAGEMENT V, LLC

    FORESITE CAPITAL OPPORTUNITY FUND V, L.P.

    FORESITE CAPITAL OPPORTUNITY MANAGEMENT V, LLC

    • 10% Owner
    • DIRECTOR BY DEPUTIZATIONDIRECTOR BY DEPUTIZATIONDIRECTOR BY DEPUTIZATIONDIRECTOR BY DEPUTIZATIONDIRECTOR BY DEPUTIZATION
    4,870,250 2021-02-05 0

    UKNIS MARC CHIEF MEDICAL OFFICER

    • Officer
    0 2021-02-05 0

    FORESITE CAPITAL OPPORTUNITY FUND V, L.P.

    FORESITE CAPITAL OPPORTUNITY MANAGEMENT V, LLC

    • 10% Owner
    441,500 2020-10-19 0

    FS DEVELOPMENT HOLDINGS, LLC

    FORESITE CAPITAL FUND V, L.P.

    FORESITE CAPITAL MANAGEMENT V, LLC

    TANANBAUM JAMES B. PRESIDENT & CEO

    • Officer
    • Director
    • 10% Owner
    441,500 2020-08-14 0

    PAKIANATHAN DEEPIKA

    • Director
    0 2020-08-11 0

    CAREY ROBERT

    • Director
    0 2020-08-11 0

    FS DEVELOPMENT HOLDINGS, LLC

    FORESITE CAPITAL FUND V, L.P.

    FORESITE CAPITAL MANAGEMENT V, LLC

    • 10% Owner
    0 2020-08-11 0

    BAJAJ VIKRAM

    • Director
    0 2020-08-11 0

    DUBIN DANIEL

    • Director
    0 2020-08-11 0

    FS DEVELOPMENT HOLDINGS, LLC

    • 10% Owner
    0 2020-08-11 0

    RYAN DENNIS D CHIEF FINANCIAL OFFICER

    • Officer
    0 2020-08-11 0

    ROME MICHAEL E VICE PRESIDENT

    • Officer
    • Director
    0 2020-08-11 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    ASHIYA MONA - Director - > 10% Owner see footnotes

    2023-02-17 16:48:58 -0500 2023-02-15 P 14,329 $23.00 a 299,205 indirect -1.237 -0.2394 1.3168 3 -2.6736 5

    ASHIYA MONA - Director - > 10% Owner see footnotes

    2023-02-17 16:48:58 -0500 2023-02-15 P 37,049 $23.00 a 773,607 indirect -1.237 -0.2394 1.3168 3 -2.6736 5

    ASHIYA MONA - Director - > 10% Owner see footnotes

    2023-02-17 16:48:58 -0500 2023-02-15 P 57,318 $23.00 a 1,196,825 indirect -1.237 -0.2394 1.3168 3 -2.6736 5

    ORBIMED ADVISORS LLC - Director - > 10% Owner see footnotes

    ORBIMED CAPITAL GP VI LLC - Director - > 10% Owner see footnotes

    ORBIMED CAPITAL GP VIII LLC - Director - > 10% Owner see footnotes

    ORBIMED GENESIS GP LLC - Director - > 10% Owner see footnotes

    2023-02-17 16:43:10 -0500 2023-02-15 P 14,329 $23.00 a 299,205 indirect -1.237 -0.2394 1.3168 3 -2.6736 5

    ORBIMED ADVISORS LLC - Director - > 10% Owner see footnotes

    ORBIMED CAPITAL GP VI LLC - Director - > 10% Owner see footnotes

    ORBIMED CAPITAL GP VIII LLC - Director - > 10% Owner see footnotes

    ORBIMED GENESIS GP LLC - Director - > 10% Owner see footnotes

    2023-02-17 16:43:10 -0500 2023-02-15 P 37,049 $23.00 a 773,607 indirect -1.237 -0.2394 1.3168 3 -2.6736 5

    ORBIMED ADVISORS LLC - Director - > 10% Owner see footnotes

    ORBIMED CAPITAL GP VI LLC - Director - > 10% Owner see footnotes

    ORBIMED CAPITAL GP VIII LLC - Director - > 10% Owner see footnotes

    ORBIMED GENESIS GP LLC - Director - > 10% Owner see footnotes

    2023-02-17 16:43:10 -0500 2023-02-15 P 57,318 $23.00 a 1,196,825 indirect -1.237 -0.2394 1.3168 3 -2.6736 5

    AI DMI LLC - > 10% Owner

    ACCESS INDUSTRIES HOLDINGS LLC - > 10% Owner

    ACCESS INDUSTRIES MANAGEMENT, LLC - > 10% Owner

    BLAVATNIK LEN - > 10% Owner

    2023-02-17 16:42:32 -0500 2023-02-15 P 434,783 $23.00 a 3,141,759 direct -1.237 -0.2394 1.3168 3 -2.6736 5

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    DISC MEDICINE INC IRON 2023-03-24 22:15:03 UTC -1.316 6.136 30000
    DISC MEDICINE INC IRON 2023-03-24 21:45:03 UTC -1.316 6.136 30000
    DISC MEDICINE INC IRON 2023-03-24 21:15:03 UTC -1.316 6.136 30000
    DISC MEDICINE INC IRON 2023-03-24 20:45:03 UTC -1.316 6.136 30000
    DISC MEDICINE INC IRON 2023-03-24 20:15:04 UTC -1.316 6.136 30000
    DISC MEDICINE INC IRON 2023-03-24 19:45:03 UTC -1.316 6.136 30000
    DISC MEDICINE INC IRON 2023-03-24 19:15:04 UTC -1.316 6.136 30000
    DISC MEDICINE INC IRON 2023-03-24 18:45:04 UTC -1.1646 5.9846 30000
    DISC MEDICINE INC IRON 2023-03-24 18:15:03 UTC -1.1646 5.9846 30000
    DISC MEDICINE INC IRON 2023-03-24 17:45:03 UTC -1.1646 5.9846 30000
    DISC MEDICINE INC IRON 2023-03-24 17:15:03 UTC -1.1646 5.9846 30000
    DISC MEDICINE INC IRON 2023-03-24 16:45:03 UTC -1.1646 5.9846 30000
    DISC MEDICINE INC IRON 2023-03-24 16:15:03 UTC -1.1646 5.9846 10000
    DISC MEDICINE INC IRON 2023-03-24 15:45:03 UTC -1.1646 5.9846 10000
    DISC MEDICINE INC IRON 2023-03-24 15:15:03 UTC -1.1646 5.9846 30000
    DISC MEDICINE INC IRON 2023-03-24 14:45:03 UTC -1.1646 5.9846 30000
    DISC MEDICINE INC IRON 2023-03-24 14:15:03 UTC -1.1646 5.9846 10000
    DISC MEDICINE INC IRON 2023-03-24 13:45:03 UTC 1.294 3.276 10000
    DISC MEDICINE INC IRON 2023-03-24 13:15:04 UTC 1.294 3.276 10000
    DISC MEDICINE INC IRON 2023-03-24 12:45:03 UTC 1.294 3.276 10000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund IRON -130.0 shares, $-2585.7 2022-12-31 N-PORT

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments